Envíe este artículo por correo electrónico ¿Patología dual? Revisando la conceptualización de la comorbilidad en adicciones
Resumen
Palabras clave
Referencias
Albert, P.R., Benkelfat, C. y Descarries, L. (2012). The neurobiology of depression—revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms. Philoshopical Transactions of the Royal Society B, 367, 2378–81.
Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., . . . Murray, R. (2018). Analysis of shared heritability in common disorders of the brain. Science, 360(6395). doi:10.1126/science.aap8757
Arango, C., Dragioti, E., Solmi, M., Cortese, S., Domschke, K., Murray, R. M., . . . Fusar-Poli, P. (2021). Risk and protective factors for mental disorders beyond genetics: An evidence-based atlas. World Psychiatry, 20(3), 417-436. doi:10.1002/wps.20894
Arranz, B., Garriga, M., Bernardo, M., González-Pinto, A., Arrojo, M., Torrens, M., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with schizophrenia spectrum disorders and a comorbid substance use. Adicciones, 34(2), 110-127. doi:10.20882/adicciones.1504
Ashford, R. D., Brown, A., Brown, T., Callis, J., Cleveland, H. H., Eisenhart, E., Groover, H., Hayes, N., Johnston, T., Kimball, T., Manteuffel, B., McDaniel, J., Montgomery, L., Phillips, S., Polacek, M., Statman, M. y Whitney, J. (2019). Defining and operationalizing the phenomena of recovery: A working definition from the recovery science research collaborative. Addiction Research y Theory, 27(3), 179-188. https://doi.org/10.1080/16066359.2018.1515352
Becoña, E. (2018). Brain disease or biopsychosocial model in addiction? Remembering the Vietnam Veteran Study. Psicothema, 30(3).
Carballo, J.L. (2023). Editorial: Sobre la recuperación en adicciones. Health and addictions, 23(1), 1-5.
Caspi, A., Houts, R. M., Ambler, A., Danese, A., Elliott, M. L., Hariri, A., . . . Moffitt, T. E. (2020). Longitudinal assessment of mental health disorders and comorbidities across 4 decades among participants in the dunedin birth cohort study. JAMA Netw Open, 3(4), e203221. doi:10.1001/jamanetworkopen.2020.3221
Caspi, A. y Moffitt, T. E. (2018). All for one and one for all: Mental disorders in one dimension. American Journal of Psychiatry, 175(9), 831-844. doi:10.1176/appi.ajp.2018.17121383
Compton, W. M., Thomas, Y. F., Stinson, F. S. y Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566-576. doi:10.1001/archpsyc.64.5.566
Cowlishaw, S. y Hakes, J. K. (2015). Pathological and problem gambling in substance use treatment: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Americal Journal of Addiction, 24(5), 467-474. doi:10.1111/ajad.12242
Cunill, R., Castells, X., González-Pinto, A., Arrojo, M., Bernardo, M., Sáiz, P. A., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use. Adicciones, 34(2), 168-178. doi:10.20882/adicciones.1569
Cuthbert, B.N. (2014). The RDoC framework: Facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry, 13(1).
Engels, G.L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129-36. doi: 10.1126/science.847460.
Fan, A. Z., Chou, S. P., Zhang, H., Jung, J. y Grant, B. F. (2019). Prevalence and correlates of past-year recovery from DSM-5 alcohol use disorder: Results from National Epidemiologic Survey on Alcohol and Related Conditions-III. Alcoholism: Clinical and Experimental Research, 43(11), 2406-2420. https://doi.org/10.1111/acer.14192
Forbes, M.K., Tackett, J.L., Markon, K.E. y Krueger, R.F. (2016). Beyond comorbidity: Toward a dimensional and hierarchal approach to understanding psychopathology across the lifespan. Development and Psychopathology, 28(4 Pt 1), 971-86. 10.1017/S0954579416000651
González-Pinto, A., Goikolea, J. M., Zorrilla, I., Bernardo, M., Arrojo, M., Cunill, R., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with bipolar disorder and comorbid substance use. Adicciones, 34(2), 142-156. doi:10.20882/adicciones.1528
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., . . . Hasin, D. S. (2015). Epidemiology of DSM-5 alcohol use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry, 72(8), 757-766. doi:10.1001/jamapsychiatry.2015.0584
Haslam, N., Holland, E. y Kuppens, P. (2021). Categories versus dimensions in personality and psychopathology: A quantitative review of taxometric research. Psychological Medicine, 42(5),903–920.
Heilig, M., McKillop, J., Rehm, J., Leggio, L. y Vanderschuren, L.J.M.J. (2021). Addiction as a brain disease revised: Why it still matters, and the need for consilience. Neuropsychopharmacology, 46, 1715-1723. https://doi.org/10.1038/s41386-020-00950-y.
Kelly, J. F., Bergman, B. G., Hoeppner, B. B., Vilsaint, C. y White, W. L. (2017). Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy. Drug and Alcohol Dependence, 181, 162-169. https://doi.org/10.1016/j.drugalcdep.2017.09.028
Kotov, R., Krueger, R.F., Watson, D., Achenbach, T.M., Althoff, R., Bagby, R.M… Brown, T.A. (2017). The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. Journal of Abnormal Psychology, 126(4), 457-477. doi: 10.1037/abn0000258.
Krueger, R. F. y Markon, K. E. (2006). Reinterpreting comorbidity: A model-based approach to understanding and classifying psychopathology. Annual Review of Clinical Psychology, 2, 111-133. doi:10.1146/annurev.clinpsy.2.022305.095213
Krueger, R.F. y Markon, K.E. (2011). A dimensional-spectrum model of psychopathology progress and opportunities. Archives of General Psychiatry, 68(1), 10-1. doi: 10.1001/archgenpsychiatry.2010.188.
Lahey, B. B., Applegate, B., Hakes, J. K., Zald, D. H., Hariri, A. R. y Rathouz, P. J. (2012). Is there a general factor of prevalent psychopathology during adulthood? Journal of Abnormal Psychology, 121(4), 971-977. doi:10.1037/a0028355
Lev-Ran, S., Imtiaz, S., Rehm, J. y Le Foll, B. (2013). Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). American Journal of Addictions, 22(2), 93-98. doi:10.1111/j.1521-0391.2013.00304.x
Lehman, A.F., Myers, C.P. y Corty, E. (1989). Assessment and classification of patients with psychiatric and substance abuse syndromes. Hospital Community Psychiatry, 40, 1019-1025.
Lüscher, C., Robins, T. W. y Everitt, B. J. (2020). The transition to compulsion in addiction. Nature Reviews Neuroscience, 21(5). 247–263. doi:10.1038/s41583-020-0289-z.
McGrath, J. J., Lim, C. C. W., Plana-Ripoll, O., Holtz, Y., Agerbo, E., Momen, N. C., . . . de Jonge, P. (2020). Comorbidity within mental disorders: A comprehensive analysis based on 145 990 survey respondents from 27 countries. Epidemiology and Psychiatric Sciences, 29, e153. doi:10.1017/s2045796020000633
Merikangas, K. R., He, J. P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., . . . Swendsen, J. (2010). Lifetime prevalence of mental disorders in U.S. adolescents: Results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). Journal of the American Academy of Child & Adolescent Psychiatry, 49(10), 980-989. doi:10.1016/j.jaac.2010.05.017
Moncrieff, J., Cooper, R.E., Stockmann, T., Amendola, S., Hengartner, M.P. y Horowitz, M.A. (2022). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28, 3243-3256.
National Institue on Drug Abuse (2020). Common Comorbidities with Substance Use Disorders Research Report. National Institutes on Drug Abuse.
Pereiro, C., Pino, C., Flórez, G., Arrojo, M. y Becoña, E. (2013). Psychiatric comorbidity in patients from the addictive disorders assistance units of Galicia: The COPSIAD study. PLoS One, 8(6), e66451. doi:10.1371/journal.pone.0066451
Plana-Ripoll, O., Pedersen, C. B., Holtz, Y., Benros, M. E., Dalsgaard, S., de Jonge, P., . . . McGrath, J. J. (2019). Exploring comorbidity within mental disorders among a Danish national population. JAMA Psychiatry, 76(3), 259-270. doi:10.1001/jamapsychiatry.2018.3658
Real Academia Nacional de Medicina de España (n.d.). Patología no es sinónimo de enfermedad. https://www.ranm.es/terminolog%C3%ADa-m%C3%A9dica/recomendaciones-de-la-ranm/3610-patologia-no-es-sinonimo-de-enfermedad.html
Room, R. (2021). No level has primacy in what is called addiction: “Addiction is a social disease” would be just as tenable. Neuropsychopharmacology, 46(1712).
Sáiz, P. A., Flórez, G., Arrojo, M., Bernardo, M., González-Pinto, A., Goikolea, J. M., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with an anxiety disorder and comorbid substance use. Adicciones, 34(2), 157-167. doi:10.20882/adicciones.1548
Sáiz Martínez, P.A., Jimenez Treviño, L., Díaz Mesa, E.M., García-Portilla González M.P., Marina González, P., Al-Halabí, S.,… Ruiz, P. (2014). Patología dual en trastornos de ansiedad: Recomendaciones en el tratamiento farmacológico. Adicciones, 26, 254-274.
Smoller, J. W., Andreassen, O. A., Edenberg, H. J., Faraone, S. V., Glatt, S. J. y Kendler, K. S. (2019). Psychiatric genetics and the structure of psychopathology. Mol Psychiatry, 24(3), 409-420. doi:10.1038/s41380-017-0010-4
Strain, E.C. (2022). Editorial: The defining characteristic of substance use disorders. Drug and Alcohol Dependence, 230. https://doi.org/10.1016/j.drugalcdep.2021.109207
Szerman, N., Torrens, M., Maldonado, R., Balhara, Y. P. S., Salom, C., Maremmani, I., . . . Baler, R. (2022). Addictive and other mental disorders: A call for a standardized definition of dual disorders. Translational Psychiatry, 12(1), 446. doi:10.1038/s41398-022-02212-5
Thompson, P., Jahanshad, N., Ching, C.R.K., Salminen, L.E., Thomopoulos, S.I., Bright, J… for the ENIGMA Consortium (2020). ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. Translational Psychiatry, 10(100). https://doi.org/10.1038/s41398-020-0705-1
Torrens, M., Tirado-Muñoz, J., Fonseca, F., Farré, M., González-Pinto, A., Arrojo, M., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with depression and a comorbid substance use disorder. Adicciones, 34(2), 128-141. doi:10.20882/adicciones.1559
Trujols, J. y Allende, S. (2018). La adicción como enfermedad: ¿Mitigando o alimentando el estigma?. Adicciones, 30(3).
Volkow, N. D., Michaelides, M. y Baler, R. (2019). The Neuroscience of Drug Reward and Addiction. Physiological Reviews, 99(4). doi: 10.1152/physrev.00014.2018.
West, R. y Brown, J. (2013). Theories of addiction. John Wiley y Sons.
World Psychiatric Association (n.d.). 10 basic points on dual Pathology: Addiction and other mental illnesses. https://www.patologiadual.es/docs/wpa-10basic-points-dual-pathology.pdf
DOI: https://doi.org/10.20882/adicciones.2053
Enlaces refback
- No hay ningún enlace refback.
